• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种朊病毒蛋白片段的神经毒性。

Neurotoxicity of a prion protein fragment.

作者信息

Forloni G, Angeretti N, Chiesa R, Monzani E, Salmona M, Bugiani O, Tagliavini F

机构信息

Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy.

出版信息

Nature. 1993 Apr 8;362(6420):543-6. doi: 10.1038/362543a0.

DOI:10.1038/362543a0
PMID:8464494
Abstract

The cellular prion protein (PrPC) is a sialoglycoprotein of M(r) 33-35K that is expressed predominantly in neurons. In transmissible and genetic neurodegenerative disorders such as scrapie of sheep, spongiform encephalopathy of cattle and Creutzfeldt-Jakob or Gerstmann-Sträussler-Scheinker diseases of humans, PrPC is converted into an altered form (termed PrPSc) which is distinguishable from its normal homologue by its relative resistance to protease digestion. PrPSc accumulates in the central nervous system of affected individuals, and its protease-resistant core aggregates extracellularly into amyloid fibrils. The process is accompanied by nerve cell loss, whose pathogenesis and molecular basis are not understood. We report here that neuronal death results from chronic exposure of primary rat hippocampal cultures to micromolar concentrations of a peptide corresponding to residues 106-126 of the amino-acid sequence deduced from human PrP complementary DNA. DNA fragmentation of degenerating neurons indicates that cell death occurred by apoptosis. The PrP peptide 106-126 has a high intrinsic ability to polymerize into amyloid-like fibrils in vitro. These findings indicate that cerebral accumulation of PrPSc and its degradation products may play a role in the nerve cell degeneration that occurs in prion-related encephalopathies.

摘要

细胞朊蛋白(PrPC)是一种分子量为33 - 35K的唾液酸糖蛋白,主要在神经元中表达。在可传播的和遗传性神经退行性疾病中,如绵羊瘙痒病、牛海绵状脑病以及人类的克雅氏病或格斯特曼 - 施特劳斯勒 - 谢inker病,PrPC会转变为一种改变的形式(称为PrPSc),这种形式通过其对蛋白酶消化的相对抗性与正常同源物区分开来。PrPSc在受影响个体的中枢神经系统中积累,其抗蛋白酶核心在细胞外聚集成淀粉样纤维。这个过程伴随着神经细胞的损失,其发病机制和分子基础尚不清楚。我们在此报告,原代大鼠海马培养物长期暴露于微摩尔浓度的对应于人PrP互补DNA推导的氨基酸序列106 - 126位残基的肽会导致神经元死亡。退化神经元的DNA片段化表明细胞死亡是通过凋亡发生的。PrP肽106 - 126在体外具有很高的内在聚合成淀粉样纤维的能力。这些发现表明PrPSc及其降解产物在脑内的积累可能在朊病毒相关脑病中发生的神经细胞变性中起作用。

相似文献

1
Neurotoxicity of a prion protein fragment.一种朊病毒蛋白片段的神经毒性。
Nature. 1993 Apr 8;362(6420):543-6. doi: 10.1038/362543a0.
2
Role of microglia and host prion protein in neurotoxicity of a prion protein fragment.小胶质细胞和宿主朊病毒蛋白在朊病毒蛋白片段神经毒性中的作用。
Nature. 1996 Mar 28;380(6572):345-7. doi: 10.1038/380345a0.
3
Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitro.四环素在体外影响合成朊蛋白肽和朊病毒蛋白(Sc型)的异常特性。
J Mol Biol. 2000 Jul 28;300(5):1309-22. doi: 10.1006/jmbi.2000.3840.
4
The 118-135 peptide of the human prion protein forms amyloid fibrils and induces liposome fusion.人朊病毒蛋白的118 - 135肽段形成淀粉样纤维并诱导脂质体融合。
J Mol Biol. 1997 Dec 5;274(3):381-93. doi: 10.1006/jmbi.1997.1382.
5
Oligodendrocytes are susceptible to apoptotic cell death induced by prion protein-derived peptides.少突胶质细胞易受朊病毒蛋白衍生肽诱导的凋亡性细胞死亡影响。
Glia. 2004 Jul;47(1):1-8. doi: 10.1002/glia.10347.
6
A neurotoxic and gliotrophic fragment of the prion protein increases plasma membrane microviscosity.朊病毒蛋白的一种神经毒性和嗜神经胶质细胞片段会增加质膜微黏度。
Neurobiol Dis. 1997;4(1):47-57. doi: 10.1006/nbdi.1997.0133.
7
[Biology of non-conventional transmissible agents or prions].[非常规传染性因子或朊病毒的生物学]
Rev Neurol (Paris). 1998 Feb;154(2):142-51.
8
Ultrastructural localization of cellular prion protein (PrPc) in synaptic boutons of normal hamster hippocampus.正常仓鼠海马突触小体中细胞朊蛋白(PrPc)的超微结构定位
C R Acad Sci III. 1995 Mar;318(3):339-44.
9
BSE: can we predict the future?疯牛病:我们能预测未来吗?
Bull Mem Acad R Med Belg. 1997;152(6):264-73.
10
PrP27-30 is a normal soluble prion protein fragment released by human platelets.
Biochem Biophys Res Commun. 1996 Jun 25;223(3):572-7. doi: 10.1006/bbrc.1996.0936.

引用本文的文献

1
Exploring immunotherapeutic strategies for neurodegenerative diseases: a focus on Huntington's disease and Prion diseases.探索神经退行性疾病的免疫治疗策略:聚焦亨廷顿舞蹈症和朊病毒病
Acta Pharmacol Sin. 2025 Jun;46(6):1511-1538. doi: 10.1038/s41401-024-01455-w. Epub 2025 Jan 31.
2
The Role of Glial Cells in Neurobiology and Prion Neuropathology.胶质细胞在神经生物学和朊病毒神经病理学中的作用。
Cells. 2024 May 14;13(10):832. doi: 10.3390/cells13100832.
3
Recognition Mechanisms between a Nanobody and Disordered Epitopes of the Human Prion Protein: An Integrative Molecular Dynamics Study.
纳米抗体与人朊病毒蛋白无规则表位间的识别机制:综合分子动力学研究
J Chem Inf Model. 2023 Jan 23;63(2):531-545. doi: 10.1021/acs.jcim.2c01062. Epub 2022 Dec 29.
4
Cytoskeleton Elements Contribute to Prion Peptide-Induced Endothelial Barrier Breakdown in a Blood-Brain Barrier In Vitro System.细胞骨架元件在血脑屏障体外系统中介导朊病毒肽诱导的内皮屏障破坏。
Int J Mol Sci. 2022 Oct 12;23(20):12126. doi: 10.3390/ijms232012126.
5
Early Stages of RNA-Mediated Conversion of Human Prions.人类朊病毒 RNA 介导转化的早期阶段。
J Phys Chem B. 2022 Aug 25;126(33):6221-6230. doi: 10.1021/acs.jpcb.2c04614. Epub 2022 Aug 16.
6
Prion strains: shining new light on old concepts.朊病毒株:为旧概念带来新曙光。
Cell Tissue Res. 2023 Apr;392(1):113-133. doi: 10.1007/s00441-022-03665-2. Epub 2022 Jul 7.
7
PINK1-parkin-mediated neuronal mitophagy deficiency in prion disease.朊病毒病中 PINK1-parkin 介导的神经元线粒体自噬缺陷。
Cell Death Dis. 2022 Feb 18;13(2):162. doi: 10.1038/s41419-022-04613-2.
8
Interaction of Prion Peptides with DNA Structures.朊病毒肽与DNA结构的相互作用。
ACS Omega. 2021 Dec 20;7(1):176-186. doi: 10.1021/acsomega.1c04328. eCollection 2022 Jan 11.
9
Tau Protein Interaction Partners and Their Roles in Alzheimer's Disease and Other Tauopathies.tau 蛋白相互作用伴侣及其在阿尔茨海默病和其他 tau 病中的作用。
Int J Mol Sci. 2021 Aug 26;22(17):9207. doi: 10.3390/ijms22179207.
10
Non-cell autonomous astrocyte-mediated neuronal toxicity in prion diseases.朊病毒病中非神经元细胞自主介导的星形胶质细胞毒性。
Acta Neuropathol Commun. 2021 Feb 5;9(1):22. doi: 10.1186/s40478-021-01123-8.